Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Batch Failure Rates in Biomanufacturing
Good Training and Investing in the Right Equipment Upfront Are Among Solutions
- Batch failures in biopharmaceutical manufacturing are a huge concern due to the cost of the lost batch, the additional work required to clean contaminated equipment, and the delays associated with the lost batch. The 5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production identified and quantified the ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.